These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 9875730

  • 1. Mutation screening in exons 3 and 4 of alpha-synuclein in sporadic Parkinson's and sporadic and familial dementia with Lewy bodies cases.
    El-Agnaf OM, Curran MD, Wallace A, Middleton D, Murgatroyd C, Curtis A, Perry R, Jaros E.
    Neuroreport; 1998 Dec 01; 9(17):3925-7. PubMed ID: 9875730
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Mutation in the alpha-synuclein gene and sporadic Parkinson's disease, Alzheimer's disease, and dementia with lewy bodies.
    Higuchi S, Arai H, Matsushita S, Matsui T, Kimpara T, Takeda A, Shirakura K.
    Exp Neurol; 1998 Sep 01; 153(1):164-6. PubMed ID: 9743579
    [Abstract] [Full Text] [Related]

  • 4. [Parkinson's disease, dementia with Lewy bodies, multiple system atrophy and alpha-synuclein].
    Iwatsubo T.
    Rinsho Shinkeigaku; 1999 Dec 01; 39(12):1285-6. PubMed ID: 10791099
    [Abstract] [Full Text] [Related]

  • 5. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity.
    Irizarry MC, Growdon W, Gomez-Isla T, Newell K, George JM, Clayton DF, Hyman BT.
    J Neuropathol Exp Neurol; 1998 Apr 01; 57(4):334-7. PubMed ID: 9600226
    [Abstract] [Full Text] [Related]

  • 6. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.
    Baba M, Nakajo S, Tu PH, Tomita T, Nakaya K, Lee VM, Trojanowski JQ, Iwatsubo T.
    Am J Pathol; 1998 Apr 01; 152(4):879-84. PubMed ID: 9546347
    [Abstract] [Full Text] [Related]

  • 7. The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy.
    Spillantini MG, Goedert M.
    Ann N Y Acad Sci; 2000 Apr 01; 920():16-27. PubMed ID: 11193145
    [Abstract] [Full Text] [Related]

  • 8. Molecular genetic analysis of the alpha-synuclein and the parkin gene in Parkinson's disease in Finland.
    Autere JM, Hiltunen MJ, Mannermaa AJ, Jäkälä PA, Hartikainen PH, Majamaa K, Alafuzoff I, Soininen HS.
    Eur J Neurol; 2002 Sep 01; 9(5):479-83. PubMed ID: 12220378
    [Abstract] [Full Text] [Related]

  • 9. [Study on exons 3 and 4 of alpha-synuclein gene in Chinese familial Parkinson disease patients].
    Chen X, Liu YT, Li JR, Chen L, Xu YM, Pan YH, Meng XH, Xing SH.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Dec 01; 20(6):536-8. PubMed ID: 14669226
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Importance of familial Parkinson's disease and parkinsonism to the understanding of nigral degeneration in sporadic Parkinson's disease.
    Hattori N, Shimura H, Kubo S, Wang M, Shimizu N, Tanaka K, Mizuno Y.
    J Neural Transm Suppl; 2000 Dec 01; (60):101-16. PubMed ID: 11205133
    [Abstract] [Full Text] [Related]

  • 12. Aggregation of alpha-synuclein in the pathogenesis of Parkinson's disease.
    Iwatsubo T.
    J Neurol; 2003 Oct 01; 250 Suppl 3():III11-4. PubMed ID: 14579119
    [Abstract] [Full Text] [Related]

  • 13. Beta-synuclein gene alterations in dementia with Lewy bodies.
    Ohtake H, Limprasert P, Fan Y, Onodera O, Kakita A, Takahashi H, Bonner LT, Tsuang DW, Murray IV, Lee VM, Trojanowski JQ, Ishikawa A, Idezuka J, Murata M, Toda T, Bird TD, Leverenz JB, Tsuji S, La Spada AR.
    Neurology; 2004 Sep 14; 63(5):805-11. PubMed ID: 15365127
    [Abstract] [Full Text] [Related]

  • 14. Synphilin-1 is present in Lewy bodies in Parkinson's disease.
    Wakabayashi K, Engelender S, Yoshimoto M, Tsuji S, Ross CA, Takahashi H.
    Ann Neurol; 2000 Apr 14; 47(4):521-3. PubMed ID: 10762166
    [Abstract] [Full Text] [Related]

  • 15. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA.
    Acta Neuropathol; 2003 Sep 14; 106(3):191-201. PubMed ID: 12845452
    [Abstract] [Full Text] [Related]

  • 16. Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation.
    Jensen PH, Nielsen MS, Jakes R, Dotti CG, Goedert M.
    J Biol Chem; 1998 Oct 09; 273(41):26292-4. PubMed ID: 9756856
    [Abstract] [Full Text] [Related]

  • 17. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia.
    Zarranz JJ, Alegre J, Gómez-Esteban JC, Lezcano E, Ros R, Ampuero I, Vidal L, Hoenicka J, Rodriguez O, Atarés B, Llorens V, Gomez Tortosa E, del Ser T, Muñoz DG, de Yebenes JG.
    Ann Neurol; 2004 Feb 09; 55(2):164-73. PubMed ID: 14755719
    [Abstract] [Full Text] [Related]

  • 18. Alteration in alpha-synuclein mRNA expression in Parkinson's disease.
    Kingsbury AE, Daniel SE, Sangha H, Eisen S, Lees AJ, Foster OJ.
    Mov Disord; 2004 Feb 09; 19(2):162-70. PubMed ID: 14978671
    [Abstract] [Full Text] [Related]

  • 19. Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid.
    Conway KA, Harper JD, Lansbury PT.
    Biochemistry; 2000 Mar 14; 39(10):2552-63. PubMed ID: 10704204
    [Abstract] [Full Text] [Related]

  • 20. Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies.
    Arima K, Hirai S, Sunohara N, Aoto K, Izumiyama Y, Uéda K, Ikeda K, Kawai M.
    Brain Res; 1999 Oct 02; 843(1-2):53-61. PubMed ID: 10528110
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.